Search results
Results from the WOW.Com Content Network
A Q2 update about the progress of a late-stage clinical study provides a nice boost to the clinical-stage biotech stock. Why Inovio Pharmaceuticals, Inc. Stock Is Jumping 12.4% Today Skip to main ...
Shares of vaccine researcher Inovio Pharmaceuticals (INO) are currently trading around the $15 level, and one analyst thinks that's a bargain. Oppenheimer analyst Hartaj Singh makes the argument ...
(See Inovio stock-price forecast on TipRanks)To find good ideas for biotech stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of ...
Inovio Pharmaceuticals, Inc. is an American ... vaccine's efficacy in order to boost its stock price. [8] ... Inc. Common Stock (INO) News ...
Today's call will review our corporate and financial information for the quarter ended September 30th, 2024, as well as provide a general business update. ... Before you buy stock in Inovio ...
And just like that, the tides have turned for Inovio Pharmaceuticals (INO). Shares of the high-flying biotech dropped last week by 31%, the vast majority of which came after the release of interim ...
This week, one of the key players in the COVID-19 vaccine race took a leap forward.On Tuesday, Inovio Pharmaceuticals (INO) announced that Thermo Fisher Scientific had signed a letter of intent to ...
The stock of Inovio Pharmaceuticals (NAS:INO, 30-year Financials) shows every sign of being fairly valued, according to GuruFocus Value calculation.